Colorectal Cancer
8 videos · last 6 months shuffled daily, then older videos newest first
▶
8:33 Adagrasib Plus Cetuximab Shows Activity but Does Not Improve Survival in KRAS G12C-mutated Metas
Dr Josep Tabernero speaks to ecancer about the final analysis of the phase III KRYSTAL-10 trial evaluating adagrasib plus cetuximab as second-line treatment for KRAS G12C-mutated metastatic colorectal cancer.
▶
45:51 Country-Wide Barriers to Clinical Trial Access in Colorectal Cancer
Dr. Cecilia Monge, Medical Director in Clinical Development at Johnson & Johnson, explores barriers to colorectal cancer trial access in low- and middle-income nations, from research capacity to diverse enrollment, for the Global Colon Cancer Association.
▶
39:29 ASCO 2026: Highlights and Analysis
Associate Professor Bishal Gyawali talks to ecancer about ASCO 2026 presentations across GI, pancreatic, lung, breast and prostate cancer, including daraxonrasib in metastatic pancreatic adenocarcinoma.
▶
4:30 POLE Mutations as Predictive Biomarkers for Immunotherapy in GI Cancers
Umair Mahmood, BSc, MSc, University College London Hospital, London, UK, discusses the potential of POLE mutations as predictive biomarkers for immune checkpoint inhibitor therapy in gastrointestinal cancers.
▶
2:11 Vitamin D and Colorectal Cancer
Researchers found biological evidence that vitamin D changes the tumor microenvironment in stage I-III colon cancer. Lead author Kimmie Ng, MD, MPH, of Dana-Farber explains why those changes warrant investigation for possible anti-cancer activity.
▶
39:41 Patients as Partners in Cancer Research
SAS's The Health Pulse talks to Steve Clark, colorectal cancer patient advocate and research co-investigator, about involving patients in study design, protocols and how findings are communicated.
▶
1:14 BATTMAN Trial: Botensilimab and Balstilimab in MSS mCRC
Benjamin Schlechter, MD, Dana-Farber Cancer Institute, Boston, MA, describes the study design of the Phase III BATTMAN trial (NCT07152821), which will examine botensilimab plus balstilimab versus best supportive care in hepatic and non-hepatic microsatellite stable metastatic colorectal cancer (MSS mCRC).
▶
18:30 Lifestyle Trials For Cancer Patients and the EXCEL Clinical Trial
Dr. Culos-Reed discusses what lifestyle clinical trials are with Colorectal Cancer Canada and how these trials can help with cancer treatment, fatigue and other lifestyle factors for cancer patients.